星島(01105.HK)控股權易手 佳兆業郭曉亭3.7億元接貨何柱國28%權益
據聯交所股權披露資料,星島(01105.HK)主席何柱國於上周四(1月28日)在場外以每股1.5元減持近2.47億股,持有權益由原先31.37%降至3.37%;交易涉資近3.7億元。交易作價較星島上周停牌前收市價0.91元計,溢價64.8%。
同日,佳兆業集團(01638.HK)主席兼執行董事郭英成女兒、系內佳兆業美好(02168.HK)副主席郭曉亭,場外以每股1.5元購入星島近2.47億股,交易完成後,持股28%並成主要股東。其買入價及買入股數與何柱國減持情況一致。
截至今日(2日)傍晚5時51分,星島仍未就股權變動出通告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.